Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

During the Trading Day
224.56 +5.57 / +2.54%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
224.57 +0.01 / +0.00%
Volume: 114.9K

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-14.46% 3 years+36.08%
3 months-5.95% 5 years+33.40%
1 year+35.54% Since inception+17.21%
Data through 08/27/2015

Quote Details

Previous close$218.99
Open day’s range219.25 – 225.80
Net asset value (NAV)218.67 (08/26/2015)
Daily volume2,645,801
Average volume (3 months)1,453,675
Data as of 3:59pm ET, 08/27/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+33.40%+26.72%
Expense Gross exp ratio0.35%0.46%
Risk 5 year sharpe ratio1.381.76
Net assets$2.9B$2.2B
Average market cap$2.4B$38.7B
Average P/E--26.0
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ANAC Anacor Pharmaceuticals Inc1.98%
RDUS Radius Health Inc1.51%
EXEL Exelixis Inc1.48%
PRTA Prothena Corporation PLC1.34%
XON Intrexon Corp1.34%
ZIOP ZIOPHARM Oncology Inc1.31%
DVAX Dynavax Technologies Corp1.29%
OPHT Ophthotech Corp1.28%
RARE Ultragenyx Pharmaceutical Inc1.26%
KYTH KYTHERA Biopharmaceuticals Inc1.26%

Partner Offers